Please login to the form below

Not currently logged in
Email:
Password:

Forendo Pharma

This page shows the latest Forendo Pharma news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    For an indepth analysis of these deals, read'Pharma deals during October 2014'. ... 335. Forendo Pharma/Apricus Biosciences. Licence [A]. Fispemifene a selective oestrogen modulator in P2 for secondary hypogonadism.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • David Colpman joins Forendo Pharma’s board David Colpman joins Forendo Pharma’s board

    He becomes a non-executive director. Forendo Pharma, a drug development company, has appointed David Colpman to its board of directors. ... Risto Lammintausta, chief executive officer of Forendo Pharma, said: “We are delighted to welcome David with his

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?
...